Explore our featured stock ideas and investment opportunities to make informed decisions in today's market.
View AllLatest Omega Fund Management, LLC Stock Portfolio
$123Million
Equity Portfolio Value
Last Reported on: 14 Feb, 2024
About Omega Fund Management, LLC and it’s 13F Hedge Fund Stock Holdings
Omega Fund Management, LLC is a hedge fund based in Boston, MA. On 12-Jun-2023, the fund reported that it had an AUM (Regulated Assets under Management) of $1.4 Billions. In it's latest 13F Holdings report, Omega Fund Management, LLC reported an equity portfolio of $108.9 Millions as of 30 Sep, 2023.
The top stock holdings of Omega Fund Management, LLC are REPL, NUVB, IKNA. The fund has invested 47.2% of it's portfolio in REPLIMUNE GROUP and 18.6% of portfolio in NUVATION BIO.
They significantly reduced their stock positions in ALPINE IMMUNE SCIENCES (ALPN).
The top stock holdings of Omega Fund Management, LLC are REPL, NUVB, IKNA. The fund has invested 47.2% of it's portfolio in REPLIMUNE GROUP and 18.6% of portfolio in NUVATION BIO.
They significantly reduced their stock positions in ALPINE IMMUNE SCIENCES (ALPN).
New Buys
| Ticker | $ Bought |
|---|---|
| LEXEO THERAPEUTICS | 28,955,300 |
| ENGENE HOLDINGS INC. | 10,440,700 |
| ENGENE HOLDINGS INC. | 403,815 |
New stocks bought by Omega Fund Management, LLC
Additions
Reductions
Sold off
| Ticker | $ Sold |
|---|---|
| ALPINE IMMUNE SCIENCES | -1,759,860 |
Omega Fund Management, LLC got rid off the above stocks
Current Stock Holdings of Omega Fund Management, LLC
Last Reported on: 14 Feb, 2024| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options |
|---|---|---|---|---|---|---|---|
| ALPN | ALPINE IMMUNE SCIENCES | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| IKNA | IKENA ONCOLOGY | 3.59 | 2,249,120 | 4,430,770 | UNCHANGED | 0.00 | |
| IMUX | IMMUNIC INC | 2.17 | 1,788,160 | 2,682,240 | UNCHANGED | 0.00 | |
| KRON | KRONOS BIO | 3.87 | 3,818,280 | 4,772,850 | UNCHANGED | 0.00 | |
| MORF | MORPHIC HOLDING | 7.25 | 309,846 | 8,948,350 | UNCHANGED | 0.00 | |
| NUVB | NUVATION BIO | 18.44 | 15,072,300 | 22,759,200 | UNCHANGED | 0.00 | |
| REPL | REPLIMUNE GROUP | 20.50 | 3,001,320 | 25,301,100 | UNCHANGED | 0.00 | |
| SANA | SANA BIOTECHNOLOGY, INC. | 2.79 | 843,750 | 3,442,500 | UNCHANGED | 0.00 | |
| SNTI | SENTI BIOSCIENCES, INC. | 0.10 | 195,792 | 129,223 | UNCHANGED | 0.00 | |
| SPRB | SPRUCE BIOSCIENCES | 5.13 | 2,161,020 | 6,331,790 | UNCHANGED | 0.00 | |
| SYRS | SYROS PHARMACEUTICALS | 1.59 | 251,270 | 1,957,390 | UNCHANGED | 0.00 | |
| THRX | THESEUS PHARMACEUTICALS | 2.33 | 711,479 | 2,881,490 | UNCHANGED | 0.00 | |
| LEXEO THERAPEUTICS | 23.46 | 2,157,620 | 28,955,300 | NEW | |||
| ENGENE HOLDINGS INC. | 8.46 | 1,131,180 | 10,440,700 | NEW | |||
| ENGENE HOLDINGS INC. | 0.33 | 475,077 | 403,815 | NEW |